At a meeting held by the Food and Drug Administration on July 21, 2025, a panel convened by the agency cast doubt on the safety of antidepressant medications called selective serotonin reuptake inhibitors, or SSRIs, in pregnancy.
Panel…
How FDA panelists casting doubt on antidepressant use during pregnancy could lead to devastating outcomes for mothers
